HAP Trading’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.22M | Sell |
28,300
-1,700
| -6% | -$1.27M | 0.09% | 149 |
|
|
2025
Q2 | $1.14M | Buy |
30,000
+15,500
| +107% | +$12M | 0.11% | 109 |
|
|
2025
Q1 | $947K | Sell |
14,500
-9,700
| -40% | -$8.07M | 0.1% | 131 |
|
|
2024
Q4 | $1.08M | Buy |
24,200
+6,100
| +34% | +$5.05M | 0.09% | 121 |
|
|
2024
Q3 | $1.53M | Sell |
18,100
-1,200
| -6% | -$1.08M | 0.18% | 99 |
|
|
2024
Q2 | $2.43M | Buy |
19,300
+7,000
| +57% | +$5.6M | 0.29% | 64 |
|
|
2024
Q1 | $967K | Sell |
12,300
-5,900
| -32% | -$4.2M | 0.11% | 127 |
|
|
2023
Q4 | $462K | Sell |
18,200
-2,200
| -11% | -$1.28M | 0.07% | 205 |
|
|
2023
Q3 | $771K | Sell |
20,400
-19,000
| -48% | -$9.79M | 0.12% | 157 |
|
|
2023
Q2 | $590K | Buy |
+39,400
| New | +$16.5M | 0.1% | 175 |
|
|
2023
Q1 | – | Sell |
-13,100
| Closed | -$505K | – | 1471 |
|
|
2022
Q4 | $505K | Sell |
13,100
-6,700
| -34% | -$2.38M | 0.05% | 290 |
|
|
2022
Q3 | $451K | Sell |
19,800
-2,800
| -12% | -$887K | 0.03% | 384 |
|
|
2022
Q2 | $981K | Buy |
22,600
+8,900
| +65% | +$2.67M | 0.05% | 295 |
|
|
2022
Q1 | $539K | Buy |
13,700
+2,500
| +22% | +$643K | 0.02% | 513 |
|
|
2021
Q4 | $494K | Sell |
11,200
-3,400
| -23% | -$862K | 0.01% | 683 |
|
|
2021
Q3 | $426K | Sell |
14,600
-5,900
| -29% | -$1.46M | 0.01% | 730 |
|
|
2021
Q2 | $711K | Sell |
20,500
-1,700
| -8% | -$341K | 0.02% | 547 |
|
|
2021
Q1 | $356K | Sell |
22,200
-5,700
| -20% | -$1.11M | 0.02% | 592 |
|
|
2020
Q4 | $405K | Buy |
27,900
+14,700
| +111% | +$2.19M | 0.01% | 696 |
|
|
2020
Q3 | $101K | Buy |
13,200
+600
| +5% | +$92.9K | 0.01% | 792 |
|
|
2020
Q2 | $195K | Sell |
12,600
-1,200
| -9% | -$184K | 0.01% | 693 |
|
|
2020
Q1 | $125K | Buy |
+13,800
| New | +$1.9M | 0.01% | 632 |
|
|
2019
Q2 | – | Sell |
-690,200
| Closed | -$10.4M | – | 1253 |
|
|
2019
Q1 | $10.4M | Buy |
690,200
+333,500
| +93% | +$40.6M | 0.92% | 28 |
|
|
2018
Q4 | $3.45M | Buy |
+356,700
| New | +$39.8M | 0.22% | 95 |
|
|
2017
Q2 | – | Sell |
-15,700
| Closed | -$65K | – | 1074 |
|
|
2017
Q1 | $65K | Buy |
15,700
+5,200
| +50% | +$416K | ﹤0.01% | 639 |
|
|
2016
Q4 | $16K | Sell |
10,500
-42,200
| -80% | -$3.14M | ﹤0.01% | 798 |
|
|
2016
Q3 | $147K | Buy |
52,700
+39,600
| +302% | +$3.17M | 0.01% | 548 |
|
|
2016
Q2 | $41K | Buy |
+13,100
| New | +$986K | ﹤0.01% | 628 |
|
|
2015
Q4 | – | Sell |
-19,300
| Closed | -$67K | – | 1043 |
|
|
2015
Q3 | $67K | Sell |
19,300
-37,700
| -66% | -$3.18M | ﹤0.01% | 670 |
|
|
2015
Q2 | $405K | Buy |
57,000
+30,000
| +111% | +$2.29M | 0.02% | 371 |
|
|
2015
Q1 | $85K | Buy |
+27,000
| New | +$1.92M | 0.01% | 554 |
|
|
2014
Q4 | – | Sell |
-300,400
| Closed | -$1.51M | – | 1134 |
|
|
2014
Q3 | $1.51M | Buy |
+300,400
| New | +$19M | 0.06% | 278 |
|
|
2014
Q1 | – | Sell |
-62,400
| Closed | -$1K | – | 1225 |
|
|
2013
Q4 | $1K | Buy |
+62,400
| New | +$3.12M | ﹤0.01% | 1168 |
|
Other funds holding LLY
HAP Trading's LLY Position: Q1 2025 in Review
HAP Trading sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 10,545 shares — an estimated $8.77M sold.
HAP Trading first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $17.2M in Q3 2016. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- HAP Trading reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
- HAP Trading sold 10,545 Eli Lilly shares in Q1 2025, an estimated $8.77M.
- HAP Trading first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
- HAP Trading's Eli Lilly position peaked at $17.2M in Q3 2016.
- 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on HAP Trading's 13F filing for Q1 2025, filed 14 May 2025.